OIP5 and colorectal cancer: Both OIP5‐AS1 and DYRK1A were discovered to be downregulated in radioresistant colorectal cancer cells, and OIP5‐AS1 indirectly upregulates DYRK1A expression via miR‐369‐3p binding and suppression, resulting in the reduction of colorectal cancer cell viability.24